skip to Main Content

Ulster University Scientists Target Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
The cancer has one of the lowest survival rates, with fewer than 5% of patients surviving five or more years after diagnosis.  The idea is to deliver oxygen to the tumour and improve radiotherapy treatments.

The treatment will not be available for a number of years.  Survival rates had not improved in 40 years, said Prof John Callan, who is leading the Ulster University research. Read more . . .


Back To Top